Vimarsana
Biggest News Aggregation in the World

Page 5 - Universal Immunization Programme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Universal Immunization Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Universal Immunization Programme Today - Breaking & Trending Today

J.P.Nadda launches Rotavirus vaccine | OdishaChannel.com - Vimarsana News

J.P.Nadda launches Rotavirus vaccine | OdishaChannel.com

The vaccine is being introduced initially in Andhra Pradesh, Haryana, Himachal Pradesh and Odisha and will be expanded to the entire country.

Thinking Out-of-Box in Addressing Communication and Service Delivery Challenges: Use of a Traditional Communication Method for Improving Immunization Coverage in Remote Rural Hard-to-Reach Areas of India - Vimarsana News

Thinking Out-of-Box in Addressing Communication and Service Delivery Challenges: Use of a Traditional Communication Method for Improving Immunization Coverage in Remote Rural Hard-to-Reach Areas of India

"We saw the crowd of mothers going to the vaccination sites with the sound of drum beating that we did not see before." - community leader of Rajpura block Providing immunisation services and communication with caregivers has been challenging in Sirmaur, a largely mountainous, remote rural district in the state of Himachal Pradesh, India.

Japanese Encephalitis Vaccines Market size to grow by USD 58.27 million from 2021 to 2026, Driven by inclusion in the national immunization plan - Vimarsana News

Japanese Encephalitis Vaccines Market size to grow by USD 58.27 million from 2021 to 2026, Driven by inclusion in the national immunization plan

/PRNewswire/ -- The Japanese encephalitis vaccine market size is estimated to increase by USD 58.27 million from 2021 to 2026. The market growth will progress...

Hyderabad-based Indian Immunologicals to manufacture measles-rubella vaccine - Vimarsana News

Hyderabad-based Indian Immunologicals to manufacture measles-rubella vaccine

Measles immunization directly contributes to the reduction of under-five child mortality

Hyderabad-based IIL gets DCGI's, State admin's approval to manufacture MR vaccine - Vimarsana News

Hyderabad-based IIL gets DCGI's, State admin's approval to manufacture MR vaccine

Hyderabad-based Indian Immunologicals Limited (IIL), a vaccine manufacturer has announced receipt of approval from Drugs Controller General of India (DCGI) and State Drug Control Administration for manufacture of Measles-Rubella (MR) Vaccine. This is the outcome of the Indo-Vietnam partnership,